Narrativa Raises An Additional $1.3M To Help Pharma Companies Accelerate The Fda Drug Approval Process Through Artificial Intelligence Natural Language Generation
Narrativa Raises An Additional $1.3M To Help Pharma Companies Accelerate The Fda Drug Approval Process Through Artificial Intelligence Natural Language Generation
05/18/21, 1:28 PM
Location
los angelesMoney raised
$1.3 million
Round Type
seed
Narrativa, which has built an artificial intelligence (AI) medical writing platform to help pharmaceutical companies accelerate the drug approval process and lower the overall cost of compliance, recently closed its $1.3 million financing round.
Company Info
Location
los angeles, california, united states
Additional Info
Founded in 2015, Narrativa was created from the belief that technology can be used to transform the world in a positive way. Recognized by Samsung as one of the most important companies in the NLG field, Narrativa supports businesses that want to grow by anticipating trends and transforming data into human language in real time. Through its artificial intelligence system and experience in machine learning, Narrativa produces automated content in diverse fields, including finance, pharmaceuticals, insurance, media, and gaming among others. Visit www.Narrativa.com to learn more.
Contact:Matthew RectorNarrativa, USA[email protected] Direct: (323) 487-2901
Sofia SanchezNarrativa, International[email protected]
SOURCE Narrativa